Effect of Tongmaiyin combined with rivaroxaban on factors of deep vein thrombosis of lower extremity after operation of intertrochanteric fracture of femur in elderly patients
Objective Analysis of the Effects of Tongmai Drink and Rivaroxaban on Postoperative Lower Extremity Deep Vein Thrombosis Formation in Elderly Patients with Intertrochanteric Fractures.Methods Data from 100 confirmed patients treated from January 2022 to January 2023 were analyzed in the Sixth Medical Center of the General Hospital of the People's Liberation Army.The patients were randomly divided into a study group and a control group,with 50 patients in each group.After admission,both groups underwent complete examinations,and post-surgery observations were made in the anesthesia recovery room.Following assessment by an anesthesiologist,patients were transferred to the ward for dynamic monitoring of vital signs.Postoperatively,the control group received Rivaroxaban,while the study group received Tongmai Drink in addition to Rivaroxaban.Both groups were treated for 35 days and followed up one month after surgery.The conditions of the lower limbs and changes in relevant laboratory indicators were observed,and the incidence rates of postoperative venous thromboembolism and adverse drug reactions during the medication period were recorded.Results On the 10th and 15th day after surgery in both groups,the lower limb circumference difference in the study group was smaller than that in the control group(t=5.781～17.295,all P＜0.001).After the same intervention time of 7 days,the coagulation related indicators and hemorheological indicators in the study group were better than those in the control group(t=2.047～5.021,all P＜0.05).Follow up after discharge showed that 4 cases in the study group had bleeding events,3 cases had deep vein thrombosis in the lower limbs;7 cases in the control group had bleeding events,and 10 cases had deep vein thrombosis in the lower limbs(χ2=0.706,4.000,P=0.401,0.046).Conclusion The combination of Tongmai Drink and Rivaroxaban is beneficial for reducing postoperative risk in elderly patients,thereby promoting better patient outcomes.
RivaroxabanElderly intertrochanteric fracture of femurTongmaiyinPostoperative venous thromboembolism
万方数据
维普
